Gene Name | SNP name | Location | Allelesa | MAFb | Pc | %vard |
---|---|---|---|---|---|---|
Versican | VCAN_1 | Exon 8 | A/G | 0.45 | n.s. | 0.2 |
Versican | VCAN_2 | Exon 8 | G/A | 0.45 | n.s. | 0.4 |
Versican | VCAN_3 | Exon 8 | T/G | 0.45 | n.s. | 0.4 |
Versican | VCAN_4 | Exon 8 | C/T | 0.45 | n.s. | 0.2 |
Versican | VCAN_5 | Exon 8 | C/A | 0.38 | n.s. | 0.4 |
Versican | VCAN_6 | Exon 8 | C/T | 0.38 | n.s. | 0.4 |
Leukemia inhibitory factor | LIF_1 | Intron 1 | A/G | 0.47 | 0.001 | 8.6 |
Matrix metallopeptidase 13 | MMP13_1 | Intron 7 | G/A | 0.33 | n.s. | 0.08 |
Matrix metallopeptidase 13 | MMP13_2 | Intron 7 | T/G | 0.33 | n.s. | 0.05 |
Matrix metallopeptidase 13 | MMP13_3 | Exon 8 | A/G | 0.33 | n.s. | 0.1 |
Matrix metallopeptidase 13 | MMP13_4 | Intron 8 | C/T | 0.33 | n.s. | 0.03 |
Matrix metallopeptidase 13 | MMP13_5 | Intron 8 | T/C | 0.32 | n.s. | 0.01 |
Matrix metallopeptidase 13 | MMP13_6 | Intron 8 | G/T | 0.33 | n.s. | 0.3 |
Oncostatin M | OSM_1 | Exon 3 | C/T | 0.47 | 0.001 | 7.7 |
Oncostatin M | OSM_2 | Exon 3 | T/C | 0.47 | 0.001 | 8.6 |
Oncostatin M | OSM_3 | Exon 3 | T/C | 0.47 | 0.001 | 8.6 |
Oncostatin M | OSM_4 | Exon 3 | G/T | 0.47 | 0.0008 | 8.6 |
Oncostatin M | OSM_5 | Exon 3 | A/G | 0.47 | 0.001 | 8.6 |
Oncostatin M | OSM_6 | Intron 3 | C/T | 0.47 | 0.001 | 7.7 |
Oncostatin M | OSM_7 | Intron 3 | T/C | 0.47 | 0.001 | 7.7 |
Oncostatin M | OSM_8 | Intron 3 | A/G | 0.47 | 0.001 | 7.7 |
Pyrroline-5-carboxylate reductase 1 | PYCR1_1 | 5’ UTR | A/T | 0.11 | n.s. | 2.5 |
Pyrroline-5-carboxylate reductase 1 | PYCR1_2 | 5’ UTR | C/T | 0.13 | n.s. | 1.0 |
Pyrroline-5-carboxylate reductase 1 | PYCR1_3 | Intron 1 | C/T | 0.03 | n.s. | 1.0 |
Vimentin | VIM_1 | Intron 5 | C/T | 0.21 | n.s. | 0.2 |
Vimentin | VIM_2 | Intron 5 | A/G | 0.36 | n.s. | 0.3 |
Vimentin | VIM_3 | Intron 5 | C/T | 0.17 | n.s. | 0.01 |
Vimentin | VIM_4 | Intron 5 | A/G | 0.19 | n.s. | 0.6 |
Vimentin | VIM_5 | Intron 5 | C/T | 0.15 | n.s. | 0.00 |
Vimentin | VIM_6 | Intron 5 | C/A | 0.34 | n.s. | 0.3 |
Vimentin | VIM_7 | Intron 5 | C/A | 0.11 | n.s. | 0.7 |